• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY TORIC EXTENDED VISION UV ABSORBING IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY TORIC EXTENDED VISION UV ABSORBING IOL; INTRAOCULAR LENS Back to Search Results
Model Number DAT415
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Visual Impairment (2138); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 12/10/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The product has not been returned to the manufacturing site.Based on the results from the product and batch history record, the product met release criteria.Root cause cannot be identified at this time.Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.There have been no other complaints reported in the lot number.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A facility representative reported that following implantation of an intraocular lens (iol) the patient experienced vision difficulty and cotton wool spots (retina problem).The lens was explanted.New information received reporting the patient was sent to explant.Post operation of 7 days patient experienced vision difficulties and cotton wool spots (retinal problem).
 
Additional Manufacturer Narrative
The product was not returned.Product history records were reviewed and the documentation indicated the product met release criteria.The customer indicated the use of a qualified company cartridge and handpiece.The customer indicated the use of a viscoelastic, which is not qualified for the lens/company cartridge/handpiece combination used.Information was provided that in the surgeon's opinion the lens did not cause or contribute to the event.The patient saw a retina specialist and was found to have cw spots ou.Cw spots believed to be caused by covid.Patient had prior lasik surgery.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ VIVITY TORIC EXTENDED VISION UV ABSORBING IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
MDR Report Key11921696
Report Number1119421-2021-01148
Device Sequence Number11580444
Product Code POE
UDI-Device Identifier00380652427968
UDI-Public380652427968
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 07/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/08/2025
Device Model NumberDAT415
Device Lot Number15057650
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 05/10/2021
Supplement Date Received by Manufacturer07/04/2021
Initial Report FDA Received Date06/02/2021
Supplement Report FDA Received Date07/07/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MONARCH III CARTRIDGE D; MONARCH III IOL DELIVERY SYSTEM; OVD:AMVISC; MONARCH III CARTRIDGE D; MONARCH III IOL DELIVERY SYSTEM; OVD:AMVISC
Outcome Attributed to Adverse Event Required Intervention;
Patient Age71 YR
-
-